We’ve partnered with 3D content platform Sketchfab to develop an exciting new feature for journals on Taylor & Francis Online. 3D models, which are often produced by researchers in fields such as archaeology, conservation, and biomechanics, can now be published in the main text of an article. This pilot program makes Taylor & Francis the… Read more »
Contributions are welcomed in the form of original research papers reporting the results of early or late stage clinical investigations or HE/OR data on orphan drugs and studies in the treatment of rare diseases. Prior publication: Expert Opinion will only consider work that has not been previously published in full. Abstract, poster or oral presentations do… Read more »
I am often asked by students and early career researchers, how can I have a successful research and publications career? And what tips can you give me? These questions are asked as if there is some magic formula to follow which, if got right, will lead to academic success. I reply in all honesty that… Read more »
Scope: The aim of a Meta-opinion is to comment on the variety of opinions given in recent papers in the field and to suggest a consensus on the direction of the field, based on these and the author’s own opinion. Word limit: The word limit for Meta-opinions is 2,000-2,500 words (not including figures, tables and… Read more »
Word limit: The word limit for Key Paper Evaluations is 1,000-1,500 words (not including summary, keywords and references). Every article must contain: Title: Should be concise but informative, including the drug and therapeutic indication. Titles should not contain brand names Authors’ names and addresses: Including address, academic qualifications and job titles of all authors, as… Read more »
Scope: The aim of Clinical Trial Evaluations is to evaluate the quality of design and implementation of a pivotal study. The author should provide a balanced and contextualised discussion of the trial and its results and not simply summarise the original publication. Word limit: The word limit for Clinical Trial Evaluations is 1,000-1,500 words (not… Read more »
Scope: Treatment Evaluations review the clinical data on one drug for one approved indication. They should include content on efficacy and how the drug compares to other approved products for the indication under discussion. The purpose of the Treatment Evaluation is to promote best practice in use of the drug and should, therefore, be limited… Read more »
Word limit: The word limit for Pharmacoeconomic Evaluations is 3,000 words (not including figures, tables or references). Every article must contain: Title: All article types should have a concise, informative title that contains no brand names. Authors’ names and affiliation: Including address, academic qualifications and job titles of all authors, as well as telephone number… Read more »
Contributions are welcomed in the form of: Basic mechanism of action studies for investigative and marketed drugs. In vivo and in vitro studies, animal models, screening, assays, knockout studies, gene expression/function studies. Target selection and validation studies. Prior publication: Expert Opinion will only consider work that has not been previously published in full. Abstract, poster… Read more »
Contributions are welcomed in the form of: Full-length primary research papers reporting the original results of clinical investigations on agents that are in Phase III and IV clinical trials. Pharmacologically based studies with a strong link to clinical practice, both in primary and secondary (hospital) care settings, particularly those that have significant implication for clinical… Read more »
